greeksoup/ stock research
Stock research / United States / ANIP / Planned sales

ANI Pharmaceuticals Inc. planned insider sales

In the twelve months since 11 October 2025 insiders at ANI Pharmaceuticals Inc. filed 14 Form 144 notices of planned sales, 128,889 shares worth $10.1 million at the time of filing, from 7 sellers. The latest, filed 15 September 2026: Nikhil Lalwani (director, officer), 5,400 shares worth $380,160, planned for around 15 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleBrokerHow acquiredFiling
15 September 2026Nikhil LalwaniDirector, Officer5,400$380,16015 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock AwardsForm 144
11 September 2026Jeanne ThomaDirector1,000$71,46011 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock AwardsForm 144
25 August 2026Nikhil LalwaniDirector, Officer5,400$400,51825 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRSAForm 144
29 July 2026Stephen P CareyOfficer6,163$499,45029 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock AwardsForm 144
7 July 2026Patrick WalshDirector4,336$373,7207 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
8 June 2026Thomas HaugheyDirector2,000$162,2208 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock AwardsForm 144
5 June 2026Stephen P CareyOfficer11,862$939,4705 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock Options; Restricted Stock AwardsForm 144
13 May 2026Walsh Patrick DDirector10,000$795,60013 May 2026Charles Schwab CorpOpen Market PurchaseForm 144
11 May 2026Patrick WalshDirector3,973$320,82011 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
11 May 2026Nikhil LalwaniOfficer, Director55,000$4.3 million11 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesPerformance Shares; Restricted StockForm 144
5 March 2026Stephen P CareyOfficer7,312$552,0175 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock; Stock Option ExerciseForm 144
3 March 2026Patrick WalshDirector6,000$445,3903 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
9 December 2025Renate Plawner Tannenbaum 2024 Rv TrustDirector1,800$146,0705 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted stock vesting under a registered planForm 144
13 November 2025Patrick WalshDirector8,643$750,91413 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.

Source

Form 144 filings on EDGAR for ANI Pharmaceuticals Inc.: the company's filing index, each notice read from its own XML.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install